PDF herunterladen
Clin Colon Rectal Surg 2007; 20(1): 018-027
DOI: 10.1055/s-2007-970196
Copyright © 2007 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Bacterial Colitis

Harry T. Papaconstantinou1 , J. Scott Thomas1
  • 1Department of Surgery, Division of Surgical Oncology, Section of Colon and Rectal Surgery, The Texas A&M University System Health Science Center, Scott and White Hospital, Temple, Texas
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
28. Februar 2007 (online)

Auch verfügbar auf
    Lizenzen und Reprints

ABSTRACT

Bacterial colitis results in an inflammatory-type diarrhea that is characterized by bloody, purulent, and mucoid stool. These diseases have been designated as bacterial hemorrhagic enterocolitis. Associated symptoms include fever, tenesmus, and severe abdominal pain. The pathologic changes range from superficial exudative enterocolitis to a transmural enterocolitis with ulceration. Common pathologic bacteria causing bacterial colitis include Campylobacter, Salmonella, Shigella, Escherichia, and Yersinia species. The primary source of transmission is fecal-oral spread and ingestion of contaminated food and water. Although detailed history and identification of specific risk factors assist in the diagnosis, definitive diagnosis requires bacterial identification. Therefore, the physician must be familiar with the disease pathophysiology, epidemiology, and specific diagnostic modalities for clinical diagnosis and management. Specific tests are used to detect enteric pathogens and include stool and rectal swab culture, histology, and identification of specific bacterial toxins. Although many of these bacterial colitis infections are self-limiting, antibiotics should be used for high-risk patients and patients with complicated disease.

KEYWORDS

Bacteria - colitis - diarrhea - dysentery

REFERENCES

  • 1 Ilnyckyj A. Clinical evaluation and management of acute infectious diarrhea in adults.  Gastroenterol Clin North Am. 2001;  30 599-609
    CrossrefPubMedGoogle Scholar
  • 2 Ryan C A, Nickels M, Hargrett-Bean N T et al.. Massive outbreak of antimicrobial-resistant salmonellosis traced to pasteurized milk.  JAMA. 1987;  258 3269-3274
    CrossrefPubMedGoogle Scholar
  • 3 MacKenzie W R, Schell W L, Blair K A et al.. Massive outbreak of waterborne cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission.  Clin Infect Dis. 1995;  21 57-62
    PubMedGoogle Scholar
  • 4 Ina K, Kusugami K, Ohta M. Bacterial hemorrhagic enterocolitis.  J Gastroenterol. 2003;  38 111-120
    CrossrefPubMedGoogle Scholar
  • 5 Macdonald K L, O'Leary M J, Cohen M L et al.. Escherichia coli O157:H7, an emerging gastrointestinal pathogen. Results of a one-year, prospective, population-based study.  JAMA. 1988;  259 3567-3570
    CrossrefPubMedGoogle Scholar
  • 6 Peterson M C. Clinical aspects of Campylobacter jejuni infections in adults.  West J Med. 1994;  161 148-152
    PubMedGoogle Scholar
  • 7 Ebringer A, Wilson C. HLA molecules, bacteria and autoimmunity.  J Med Microbiol. 2000;  49 305-311
    PubMedGoogle Scholar
  • 8 Altekruse S F, Stern N J, Fields P I, Swerdlow D L. Campylobacter jejuni-an emerging foodborne pathogen.  Emerg Infect Dis. 1999;  5 28-35
    PubMedGoogle Scholar
  • 9 Jacobs B C, van Doorn P A, Schmitz P I et al.. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.  Ann Neurol. 1996;  40 181-187
    CrossrefPubMedGoogle Scholar
  • 10 Loss R W, Mangla J C, Pereira M. Campylobacter colitis presenting as inflammatory bowel disease with segmental colonic ulcerations.  Gastroenterology. 1980;  79 138-140
    PubMedGoogle Scholar
  • 11 Matsumoto T, Iida M, Kimura Y, Fujishima M. Culture of colonoscopically obtained biopsy specimens in acute infectious colitis.  Gastrointest Endosc. 1994;  40 184-187
    PubMedGoogle Scholar
  • 12 Oldfield E C, Wallace M R. The role of antibiotics in the treatment of infectious diarrhea.  Gastroenterol Clin North Am. 2001;  30 817-836
    CrossrefPubMedGoogle Scholar
  • 13 Smith K E, Besser J M, Hedberg C W et al.. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998.  N Engl J Med. 1999;  340 1525-1532
    CrossrefPubMedGoogle Scholar
  • 14 Levine M M. Antimicrobial therapy for infectious diarrhea.  Rev Infect Dis. 1986;  8 S207-S216
    PubMedGoogle Scholar
  • 15 Hoffner R J, Slaven E, Perez J, Magana R N, Henderson S O. Emergency department presentations of typhoid fever.  J Emerg Med. 2000;  19 317-321
    CrossrefPubMedGoogle Scholar
  • 16 Hohmann E L. Nontyphoidal salmonellosis.  Clin Infect Dis. 2001;  32 263-269
    CrossrefPubMedGoogle Scholar
  • 17 Chaudhuri A, Bekdash B A. Toxic megacolon due to Salmonella: a case report and review of the literature.  Int J Colorectal Dis. 2002;  17 275-279
    CrossrefPubMedGoogle Scholar
  • 18 Musher D M, Rubenstein A D. Permanent carriers of nontyphosa salmonellae.  Arch Intern Med. 1973;  132 869-872
    CrossrefPubMedGoogle Scholar
  • 19 Cariani G, Vandelli A. Salmonellosis-induced hemorrhage and ulcerations of the colon.  Endoscopy. 1993;  25 488
    PubMedGoogle Scholar
  • 20 Dagash M, Hayek T, Guallimidi Z, Yassin K, Brook J G. Transient radiological and colonoscopic features of inflammatory bowel disease in a patient with severe Salmonella gastroenteritis.  Am J Gastroenterol. 1997;  92 349-351
    PubMedGoogle Scholar
  • 21 Kamath R. Antibiotic therapy for Salmonella enteritis.  J Paediatr Child Health. 1999;  35 372-374
    CrossrefPubMedGoogle Scholar
  • 22 Sanchez C, Garcia-Restoy E, Garau J et al.. Ciprofloxacin and trimethoprim-sulfamethoxazole versus placebo in acute uncomplicated Salmonella enteritis: a double-blind trial.  J Infect Dis. 1993;  168 1304-1307
    PubMedGoogle Scholar
  • 23 Rodriguez-Noriega E, Andrade-Villanueva J, Amaya-Tapia G. Quinolones in the treatment of Salmonella carriers.  Rev Infect Dis. 1989;  11 S1179-S1187
    PubMedGoogle Scholar
  • 24 Kotloff K L, Winickott J P, Ivanoff B et al.. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.  Bull World Health Organ. 1999;  77 651-666
    PubMedGoogle Scholar
  • 25 DuPont H L, Hornick R B, Snyder M J, Libonati J P, Formal S B, Gangarosa E J. Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection.  J Infect Dis. 1972;  125 12-16
    PubMedGoogle Scholar
  • 26 Mohle-Boetani J C, Stapleton M, Finger R et al.. Community wide shigellosis: control of an outbreak and risk factors in child day-care centers.  Am J Public Health. 1995;  85 812-816
    PubMedGoogle Scholar
  • 27 O'Sullivan B, Delpech V, Pontivivo G et al.. Shigellosis linked to sex venues, Australia.  Emerg Infect Dis. 2002;  8 862-864
    PubMedGoogle Scholar
  • 28 Sandvig K. Shigatoxins.  Toxicon. 2001;  39 1629-1635
    CrossrefPubMedGoogle Scholar
  • 29 Bennish M L. Potentially lethal complications of shigellosis.  Rev Infect Dis. 1991;  13 S319-S324
    PubMedGoogle Scholar
  • 30 Tsuchiya N, Husby G, Williams R C et al.. Autoantibodies to the HLA-B27 sequence cross-react with the hypothetical peptide from the arthritis-associated Shigella plasmid.  J Clin Invest. 1990;  86 1193-1203
    PubMedGoogle Scholar
  • 31 Speelman P, Kabir I, Islam M. Distribution and spread of colonic lesions in Shigellosis: a colonoscopic study.  J Infect Dis. 1984;  150 899-903
    PubMedGoogle Scholar
  • 32 Khuroo M S, Mahajan R, Zargar S A et al.. The colon in Shigellosis: serial colonoscopic appearances in Shigella dysenteriae. I.  Endoscopy. 1990;  22 35-38
    PubMedGoogle Scholar
  • 33 Lawson J M. Update on Escherichia coli O157:H7.  Curr Gastroenterol Rep. 2004;  6 297-301
    PubMedGoogle Scholar
  • 34 Tarr P I, Neill M A. Escherichia coli O157:H7.  Gastroenterol Clin North Am. 2001;  30 735-751
    CrossrefPubMedGoogle Scholar
  • 35 Griffin P, Mead P, Sivapalasingam S. Escherichia coli O157:H7 and other enterohemorrhagic E. coli . In: Blaser M, Smith P, Greenberg H, et al Infections of the Gastrointestinal Tract. Philadelphia; Lippincott Williams & Wilkins 2002: 627-642
    Google Scholar
  • 36 Huang D, Okhuysen P, Jiang Z et al.. Enteroaggregative Escherichia coli: an emerging enteric pathogen.  Am J Gastroenterol. 2004;  99 383-389
    CrossrefPubMedGoogle Scholar
  • 37 Moake J L. Thrombotic microangiopathies.  N Engl J Med. 2002;  347 589-600
    CrossrefPubMedGoogle Scholar
  • 38 Crump J A, Sulka A C, Langer A J et al.. An outbreak of Escherichia coli O157:H7 infections among visitors to a dairy farm.  N Engl J Med. 2002;  347 555-560
    CrossrefPubMedGoogle Scholar
  • 39 Shigeno T, Akamatsu T, Fujimori K, Nakatsuji Y, Nagata A. The clinical significance of colonoscopy in hemorrhagic colitis due to enterohemorrhagic Escherichia coli O157:H7 infection.  Endoscopy. 2002;  34 311-314
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 40 Kelly J, Oryshak A, Wenetsek M, Grabiec J, Handy S. The colonic pathology of Escherichia coli O157:H7 infection.  Am J Surg Pathol. 1990;  14 87-92
    PubMedGoogle Scholar
  • 41 Miller F H, Ma J J, Scholz F J. Imaging features of enterohemorrhagic Escherichia coli colitis.  AJR Am J Roentgenol. 2001;  177 619-623
    PubMedGoogle Scholar
  • 42 Proulx F, Turgeon J, Delage G et al.. Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis.  J Pediatr. 1992;  121 299-303
    PubMedGoogle Scholar
  • 43 Carter A O, Borczyk A, Carlson J et al.. A severe outbreak of Escherichia coli O157:H7 associated hemorrhagic colitis in a nursing home.  N Engl J Med. 1987;  317 1496-1500
    PubMedGoogle Scholar
  • 44 Ostroff S M, Kobayashi J M, Lewis J H. Infections of Escherichia coli O157:H7 in Washington State, the first year of statewide disease surveillance.  JAMA. 1989;  262 355-359
    CrossrefPubMedGoogle Scholar
  • 45 Ryan C A, Tauxe R, Hosek G et al.. Escherichia coli O157:H7 diarrhea in a nursing home: clinical, epidemiological, and pathological findings.  J Infect Dis. 1986;  154 631-638
    PubMedGoogle Scholar
  • 46 Karch H, Strockbine N A, O'Brien A D. Growth of Escherichia coli in the presence of trimethoprim-sulfamethoxazole facilitates detection of shiga-like toxin producing strains by colony blot assay.  FEMS Microbiol Lett. 1986;  35 141-145
    CrossrefPubMedGoogle Scholar
  • 47 Zhang X, McDaniel A, Wolf L et al.. Quinolone antibiotics induce shiga toxin-encoding bacteriophages, toxin production, and death in mice.  J Infect Dis. 2000;  181 664-670
    CrossrefPubMedGoogle Scholar
  • 48 Cimolai N, Carter J, Morrison B et al.. Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome.  J Pediatr. 1990;  116 589-592
    PubMedGoogle Scholar
  • 49 Cribier B, Caille A, Heid E, Grosshans E. Erythema nodosum and associated diseases. A study of 129 cases.  Int J Dermatol. 1998;  37 667-672
    CrossrefPubMedGoogle Scholar
  • 50 Kato Y, Hattori Y, Ohya H, Yoshino S, Kato H. Acute terminal ileitis and Yersinia enterocolitica infection.  Gastroenterol Jpn. 1977;  12 36-43
    PubMedGoogle Scholar
  • 51 Matsumoto T, Iida M, Matsui T et al.. Endoscopic findings in Yersinia enterocolitica enterocolitis.  Gastrointest Endosc. 1990;  36 583-587
    PubMedGoogle Scholar
  • 52 Tuohy A M, O'Gorman M, Byington C, Reid B, Jackson W D. Yersinia enterocolitis mimicking disease in a toddler.  Pediatrics. 1999;  104 36
    CrossrefPubMedGoogle Scholar
  • 53 Pham J, Bell S, Lanzarone J. Biotype and antibiotic sensitivity of 100 clinical isolates of Yersinia enterocolitica. .  J Antimicrob Chemother. 1991;  28 13-18
    CrossrefPubMedGoogle Scholar
  • 54 Preston M A, Brown S, Borczyk A et al.. Antimicrobial susceptibility of pathogenic Yersinia enterocolitica isolated from Canada from 1972 to 1990.  Antimicrob Agents Chemother. 1994;  38 2121-2124
    PubMedGoogle Scholar
  • 55 Scavizzi M R, Alonso J, Philippon A, Jupeau-Vessieres A M, Guiyoule A. Failure of newer β-lactam antibiotics for murine Yersinia enterocolitica infection.  Antimicrob Agents Chemother. 1987;  31 523-526
    PubMedGoogle Scholar
  • 56 Han J K, Kim S H, Choi B I, Yeon K M, Han M C. Tuberculous colitis: findings at double-contrast barium enema examination.  Dis Colon Rectum. 1996;  39 1204-1209
    PubMedGoogle Scholar
  • 57 Horvath K D, Whelan R L, Weinstein S, Basner A L, Staugaitis S M, Greenebaum E. Isolated sigmoid tuberculosis. Report of a case.  Dis Colon Rectum. 1995;  38 1327-1330
    CrossrefPubMedGoogle Scholar
  • 58 Breiter J R, Hajjar J J. Segmental tuberculosis of the colon diagnosed by colonoscopy.  Am J Gastroenterol. 1981;  76 369-373
    PubMedGoogle Scholar
  • 59 Anand B. Abdominal tuberculosis. In: Weinstein WM, Hawkey CJ, Bosch J Clinical Gastroenterology and Hepatology. Philadelphia; Elsevier Mosby 2005: 331-336
    Google Scholar
  • 60 Guth A A, Kim U. The reappearance of abdominal tuberculosis.  Surg Gynecol Obstet. 1991;  172 432-436
    PubMedGoogle Scholar
  • 61 Lisehora G B, Peters C C, Lee Y T, Barcia P J. Tuberculous peritonitis-do not miss it.  Dis Colon Rectum. 1996;  39 394-399
    CrossrefPubMedGoogle Scholar
  • 62 Quinn T C, Goodell S E, Mkrtichian E, Schuffler M D, Wang S P, Stamm W E. Chlamydia trachomatis proctitis.  N Engl J Med. 1981;  305 195-200
    PubMedGoogle Scholar
  • 63 Tinmouth J, Rachlis A, Wesson T, Hsieh E. Lymphogranuloma venereum in North America: case reports and an update for gastroenterologists.  Clin Gastroenterol Hepatol. 2006;  4 469-473
    CrossrefPubMedGoogle Scholar
  • 64 Rompalo A M. Diagnosis and treatment of sexually acquired proctitis and proctocolitis: an update.  Clin Infect Dis. 1999;  28 S84-S90
    PubMedGoogle Scholar
  • 65 Catterall R D. Sexually transmitted disease of the anus and rectum.  Clin Gastroenterol. 1975;  4 659-669
    PubMedGoogle Scholar
  • 66 Corman M L. Colon and rectal surgery. 5th ed. Philadelphia; Lippincott Williams & Wilkins 2005: 1648-1650
    Google Scholar
  • 67 Schwebke J R, Whittington W, Rice R J, Handsfield H H, Hale J, Holmes K K. Trends in susceptibility of Neisseria gonorrhoeae to ceftriaxone from 1985-1991.  Antimicrob Agents Chemother. 1995;  39 917-920
    PubMedGoogle Scholar

Harry T PapaconstantinouM.D. 

Department of Surgery, Division of Surgical Oncology, Section of Colon and Rectal Surgery, The Texas A&M University System Health Science Center, Scott and White Hospital

2401 South 31st St., Temple, TX 76508

eMail: hpapaconstantinou@swmail.sw.org